Remove Angel Remove Blogging Remove Develop Remove Layoffs
article thumbnail

MediaLab acquires messaging app Kik, expanding its app portfolio

TechCrunch LA

Popular messaging app Kik is, indeed, “here to stay” following an acquisition by the Los Angeles-based multimedia holding company, MediaLab. In a post on Kik’s blog on Friday the MediaLab said that it has “finalized an agreement” to acquire Kik Messenger. Securities and Exchange Commission. .”

article thumbnail

Jaunt Abandons VR, Makes Big Cuts To Staff

socalTECH

Virtual reality studio and content producer Jaunt --which has a virtual reality content development effort in Los Angeles--said on Monday that it is "winding down" a number of its virtual reality products and content services, and switching its focus to augmented reality. Jaunt is based in San Francisco. READ MORE>>.

Content 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Should Startups Announce Their Funding?

Both Sides of the Table

One of the advantages of blogging, using social media, public speaking, etc as a VC is that you get a more nuanced view of these shifts by watching your own successes and failures. This is true on all of the major tech blogs. So your goal should be a steady stream of news across many different news outlets and your own blog.

Startup 355
article thumbnail

Uber Shuts Down

socalTECH

Los Angeles-based Uber, the online social networking web site run by former Friendster CEO Scott Sassa, has shut down. Uber developed software used to upload, organize, and share content through a free web site; the site also provided photo galleries, slide shows, videos, and blogs. READ MORE>>

Slides 100
article thumbnail

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

The company began a Phase 1 trial last year for an irritable bowel disease treatment…Gene therapy developer Audentes Therapeutics said it would try for a $75 million IPO …Scarsdale, NY-based Sapience Therapeutics raised a $22.5 —Enough good trial news. million in funding, according to a regulatory filing. . —With $1.25

News 40